loss in weight using Retatrutide
Reference value drawn from published research on GLP-1 multi-agonist compounds.
Provided strictly as scientific context
600
Clinical Study based on 600 calorie reduction in daily intake
Participants consumed fewer calories per day without being instructed to diet – driven by decreased appetite and satiety signaling.
Provided strictly as scientific context
28%
Reported increased energy levels in trials
Reported value in published research relating to GLP-1 multi-agonist compounds.
Provided strictly as a scientific reference point.
18.5KG
Average weight loss during clinical trial period of 48 weeks on high-dose Retatrutide.
Example data point referenced in peer-reviewed studies for GLP-1 multi-agonists.
Alluvi does not promote or imply medical use of its products.
Part of Alluvi Labs’ ongoing research program into advanced GLP-1 multi-agonist compounds.This formulation is supplies in controlled batches for laboratory analysis of stability, compound behaviour, and injection system performance. Not for human or veterinary consumption.
Our Newsletter
Enter your email address to be updated with fresh news
Receive emails updates and hot offers
RECOVERY MEETS ROUTINE
Daily gummy supplements crafted for sleep, stress, support, and muscle recovery – for rest and protein for strength, all in a clean, delicious form.
Power-Up in a Gummy
A delicious way to fuel your body with protein and creatine- Alluvi Gummy Bears are a quick convinient solution to stay ontop of daily nutreints. No scoops. No shakes. Just results.
No prep. No hassle.
Just precision dosing.
Buy Alluvi pens uk online are supplied ready-to-use – no mixing, no guesswork. Developed for controlled research applications, each unit features fixed pre-measured volumes to support consistency and reliability during laboratory evaluation. Not for human or veterinary consumption.
